Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4335 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Valeant unveils promising hepatitis drug data

The clinical study was designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of pradefovir (formerly called remofovir) in patients chronically infected with hepatitis B virus (HBV). In

Novartis reports strong Q1 performance

Group net sales were up 11% to $7.3 billion, driven by pharmaceuticals, which once again gained market share, and its recently acquired generics division Sandoz, which posted a

GSK and NanoPass get Britech grant

Called the MicroPyramid technology, this method offers the possibility to effectively and painlessly administer vaccines intra-epidermally. Conventional needles are too large to do this, and other transdermal technologies